Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leverger

Showing results (421-430 of 434) with videos related to

Pageof 44
Sort By:
Blood|April 4, 2019
Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genesJérôme Hadjadj, Nathalie Aladjidi, Helder Fernandes, et al.
British Journal of Haematology|November 14, 2018
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort studySébastien Héritier, Mohamed-Aziz Barkaoui, Jean Miron, et al.
American Journal of Hematology|March 7, 2023
Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopeniaThomas Pincez, Helder Fernandes, Marlène Pasquet, et al.
American Journal of Hematology|April 23, 2024
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcomeThomas Pincez, Helder Fernandes, Mony Fahd, et al.
Nature Communications|June 22, 2023
NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cellsLaure Delage, Francesco Carbone, Quentin Riller, et al.
Blood|November 18, 2017
A landscape of germ line mutations in a cohort of inherited bone marrow failure patientsOlivier Bluteau, Marie Sebert, Thierry Leblanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2023
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study GroupRomy E van Weelderen, Kim Klein, Christine J Harrison, et al.
Blood Advances|October 21, 2025
Childhood isolated C3d-positive AIHA: favorable prognosis but rare relapse or associated immunodeficiencyMarion Blachez, Nathalie Aladjidi, Thomas Modot, et al.
Blood|January 16, 2024
Antinuclear antibody-associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosusJérôme Granel, Helder Fernandes, Brigitte Bader-Meunier, et al.
Blood Advances|April 15, 2024
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemiaRomy E van Weelderen, Christine J Harrison, Kim Klein, et al.
Pageof 44

Showing results (421-430 of 434) with videos related to

Sort By:
Pageof 44
Blood|April 4, 2019
Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genesJérôme Hadjadj, Nathalie Aladjidi, Helder Fernandes, et al.
British Journal of Haematology|November 14, 2018
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort studySébastien Héritier, Mohamed-Aziz Barkaoui, Jean Miron, et al.
American Journal of Hematology|March 7, 2023
Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopeniaThomas Pincez, Helder Fernandes, Marlène Pasquet, et al.
American Journal of Hematology|April 23, 2024
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcomeThomas Pincez, Helder Fernandes, Mony Fahd, et al.
Nature Communications|June 22, 2023
NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cellsLaure Delage, Francesco Carbone, Quentin Riller, et al.
Blood|November 18, 2017
A landscape of germ line mutations in a cohort of inherited bone marrow failure patientsOlivier Bluteau, Marie Sebert, Thierry Leblanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2023
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study GroupRomy E van Weelderen, Kim Klein, Christine J Harrison, et al.
Blood Advances|October 21, 2025
Childhood isolated C3d-positive AIHA: favorable prognosis but rare relapse or associated immunodeficiencyMarion Blachez, Nathalie Aladjidi, Thomas Modot, et al.
Blood|January 16, 2024
Antinuclear antibody-associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosusJérôme Granel, Helder Fernandes, Brigitte Bader-Meunier, et al.
Blood Advances|April 15, 2024
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemiaRomy E van Weelderen, Christine J Harrison, Kim Klein, et al.
Pageof 44